Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Interactive:
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Quiz
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Exams
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map

Clinical Review Quiz

  Multiple Sclerosis: Update on Treatment

Lawrence M. Samkoff, MD

Dr. Samkoff is a former Associate Professor of Clinical Neurology, New York Medical College, Valhalla, NY; a former Associate Chief, Neurology Department, Metropolitan Hospital, New York, NY; a Visiting Associate Professor, Department of Neurology - Rochester General Hospital, University of Rochester School of Medicine and Dentistry, Rochester, NY; and an Attending Neurologist, Rochester Multiple Sclerosis Clinic, Rochester, NY.

The questions below are based on the March 2002 cover article, “Multiple Sclerosis: Update on Treatment.”

Choose the single best answer for each question.


1. Which of the following is the most common initial course of multiple sclerosis (MS)?
  1. Primary progressive
  2. Progressive-relapsing
  3. Relapsing-remitting
  4. Secondary progressive
Click here to compare your answer.


2. Which of the following neurologic syndromes is rarely associated with MS?

  1. Aphasia
  2. Dementia
  3. Optic neuritis
  4. Transverse myelitis
  5. Trigeminal neuralgia
Click here to compare your answer.


3. Which of the following is the most sensitive diagnostic test for detecting MS?

  1. Computed tomography scan of the head
  2. Electroencephalography
  3. Immunoelectrophoresis of cerebrospinal fluid to detect oligoclonal bands
  4. Magnetic resonance imaging of the brain
  5. Measurement of somatosensory evoked potentials
Click here to compare your answer.

4. The major benefit of administering interferon beta or glatiramer acetate in the treatment of MS is a reduction in which of the following variables?
  1. Cognitive impairment
  2. Depression
  3. Long-term disability
  4. Pain
  5. Relapse rate
Click here to compare your answer.


5. Use of which of the following disease-modifying agents is associated with a syndrome characterized by chest discomfort, palpitations, and flushing?

  1. Glatiramer acetate
  2. Interferon beta-1a
  3. Interferon beta-1b
  4. Methylprednisolone
  5. Mitoxantrone
Click here to compare your answer.




Click here to read more about Multiple Sclerosis: Update on Treatment (Requires Adobe Acrobat Reader)






Check our archives to test your knowledge in other featured articles:

Clinical Review Quiz Archive



If you do not already have Acrobat Reader, simply click on the icon below, scroll down to the "Get the Free Acrobat Reader" heading and follow the instructions to install the program. Acrobat enables you to convert any document into an Adobe Portable Document Format (PDF) file for easy viewing.

Download Adobe Acrobat Reader


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj